US Stock Alert | Eli Lilly (LLY.US) rises over 5% at market open as it expands pharmaceutical production capacity in the United States

According to reports, Eli Lilly CEO Dave Ricks has revealed that the company will halve its originally planned investment of 2.3 billion euros (about 2.67 billion USD) in Germany. The weight-loss injection production facility located in Alzey, Rhineland-Palatinate, has already invested over 1 billion euros. Despite the reduction in production capacity, the factory still plans to start operations in 2027, but only half of the 1,000 planned positions will be retained. Ricks stated that the funds originally intended for Germany will instead be invested in Pennsylvania, USA, or used to build a completely new production facility.